Colorado AMC REACH Hub
科罗拉多 AMC REACH 中心
基本信息
- 批准号:10475218
- 负责人:
- 金额:$ 98.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-23 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAdoptedAreaAutoimmunityAwardBasic ScienceBiomanufacturingBladderBotoxBusinessesCancer CenterCharacteristicsClinical ResearchClinical SciencesCollaborationsColoradoDevelopmentEcosystemEducationEnsureEntrepreneurshipEvaluation ResearchFeasibility StudiesFundingGeographyGoalsGrantHealthHealth SciencesHerpes zoster diseaseHumanHyperactivityIndustryInfrastructureInstitutesIntellectual PropertyInvestmentsKineretKnowledgeLettersMedicalMentorsMentorshipPatientsPharmaceutical PreparationsProcessProductionRegenerative MedicineResearchResearch PersonnelResource DevelopmentResource SharingResourcesScientistSpeedStructureTalentsTechnologyTechnology TransferTimeTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVaccinesWorkanakinrabasecommercializationdesigneducation accessideationimprovedinnovationinquiry-based learninginvestigator traininglearning networkmyogennew technologyoperationpreventproduct developmentprogramsprototypeskill acquisitionskillssuccesstechnology developmentvalidation studies
项目摘要
SUMMARY/ABSTRACT
The goal of this project is to increase the speed and success rate of translating biomedical academic
discoveries into products improving human health. To achieve this, we propose establishing a research
evaluation and commercialization hub (Colorado REACH) at the University of Colorado Anschutz Medical
Campus (CU Anschutz), which will build programming that incorporates industry expertise, mentorship, skills
development, and access to funding and relevant resources to guide inventors from ideation through proof-of-
concept studies to early stages of product development.
The Colorado REACH hub is designed to fulfill the goals of the FOA (RFA-OD- 19-014), but is tailored to
leverage CU Anschutz’s existing assets and meet its specific needs. The university, with over 1000 active
research labs, provides a robust pipeline of diverse technologies and the scientific infrastructure required for
translational research. The Colorado REACH hub will build upon pre-existing REACH-like structures that
incorporate industry mentorship, and which rely on and provide the necessary funding, education, and access
to business and product development expertise to bridge the gap between innovative scientific ideas and the
marketplace. The REACH Hub has three major aims: (1) identify the most promising technologies and provide
funding for product definition studies, (2) promote commercialization of selected products, enable access to
technology development resources and facilitate formation of strong spinout companies, and (3) expand
educational, experiential, and networking opportunities for stakeholders.
The Colorado REACH hub will not only encourage and facilitate innovation, but itself will include innovative
characteristics: 1) an innovative governance structure to integrate the three main goals and avoid silos; 2) a
geographically focused program to expedite operations and maximize impact on the local ecosystem, but
building in ways to share resources and lessons learned with IDeA states; 3) a proactive, rather than passive,
approach to education; 4) a mentored technology development grant program that requires early interactions
between scientists, tech transfer staff, and industry consultants; and 5) an emphasis on improving academia-
industry relationships by increasing mutual understanding, ensuring robust technologies, and being responsive
to industry needs. Institutional and regional commitment to the Colorado REACH Hub is evident from the
matching funds and numerous letters of support.
摘要/摘要
该项目的目的是提高翻译生物医学学术的速度和成功率
发现产品改善人类健康的产品。为了实现这一目标,我们建议建立一项研究
科罗拉多大学Anschutz大学的评估和商业化中心(科罗拉多州范围)
校园(Cu Anschutz),该校园将构建编程,结合行业专业知识,指导,技能
开发,并获得资金和相关资源,以指导发明者从构想中通过证明
概念研究到产品开发的早期阶段。
科罗拉多范围枢纽旨在实现FOA的目标(RFA-OD- 19-014),但量身定制为
利用Cu Anschutz的现有资产并满足其特定需求。大学,有1000多个活动
研究实验室提供了强大的潜水技术和科学基础设施的强大管道。
翻译研究。科罗拉多州触及轮毂将建立在现有的类似于触及的结构的基础上
结合行业心态,并依靠并提供必要的资金,教育和访问
进入业务和产品开发专业知识,以弥合创新的科学思想与
市场。 REACH HUB具有三个主要目的:(1)确定最有前途的技术并提供
用于产品定义研究的资金,(2)促进选定产品的商业化,可以访问
技术开发资源并促进建立强大的旋转公司,(3)扩展
利益相关者的教育,经验丰富和网络的机会。
科罗拉多到达中心不仅会鼓励和促进创新,而且本身将包括创新
特征:1)创新的治理结构,以整合三个主要目标并避免孤岛; 2)a
以地理位置为重点的计划加快操作并最大程度地影响对当地生态系统的影响,但
建立与思想状态共享资源和经验教训的方式; 3)主动而不是被动的
教育方法; 4)需要早期互动的指导技术发展赠款计划
科学家,技术转移人员和行业顾问之间; 5)强调改善学术界 -
通过提高相互理解,确保强大的技术和响应迅速的行业关系
满足行业需求。机构和地区对科罗拉多州触及枢纽的承诺可以从
匹配资金和众多支持信。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model.
- DOI:10.1002/2211-5463.13625
- 发表时间:2023-07
- 期刊:
- 影响因子:2.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD C DUKE其他文献
RICHARD C DUKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD C DUKE', 18)}}的其他基金
Next Generation Autologous TIL Cancer Therapy: Development of GMP manufacturing process
下一代自体 TIL 癌症疗法:GMP 制造工艺的开发
- 批准号:
10685604 - 财政年份:2022
- 资助金额:
$ 98.58万 - 项目类别:
Development of whole yeast-based hepatitis C vaccines and Immunotherapeutics
基于全酵母的丙型肝炎疫苗和免疫疗法的开发
- 批准号:
7136398 - 财政年份:2006
- 资助金额:
$ 98.58万 - 项目类别:
Development of whole yeast-based hepatitis C vaccines and Immunotherapeutics
基于全酵母的丙型肝炎疫苗和免疫疗法的开发
- 批准号:
7274291 - 财政年份:2006
- 资助金额:
$ 98.58万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS
BPCA 儿科治疗的创新试验设计和检测开发
- 批准号:
10936040 - 财政年份:2023
- 资助金额:
$ 98.58万 - 项目类别:
Nickel Cross-Coupling Cascades with α-Heteroatom Radicals to Prepare Sterically Hindered Alcohols and Amines
镍与α-杂原子自由基交叉偶联级联制备位阻醇和胺
- 批准号:
10604535 - 财政年份:2023
- 资助金额:
$ 98.58万 - 项目类别:
Enantioselective Thioetherification of Olefins Guided by CuH Catalysis
CuH 催化下烯烃的对映选择性硫醚化
- 批准号:
10464729 - 财政年份:2022
- 资助金额:
$ 98.58万 - 项目类别:
Computational Toolkit for Normalizing the Impact of CT Acquisition and Reconstruction on Quantitative Image Features
用于标准化 CT 采集和重建对定量图像特征影响的计算工具包
- 批准号:
10530062 - 财政年份:2022
- 资助金额:
$ 98.58万 - 项目类别:
Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project
促进道德神经技术学术界与工业界的伙伴关系:利益相关者参与和工具包开发项目
- 批准号:
10655632 - 财政年份:2022
- 资助金额:
$ 98.58万 - 项目类别: